Sage Revell

Sage Revell is a market leader in the health care, life sciences, and technology sectors. She advises on national and cross-border mergers and acquisitions, venture capital, private equity, corporate reorganizations, licensing deals, collaboration agreements, and regulatory and strategic advisory matters. On the venture capital side, Sage represents emerging-growth companies and the investors who support them from the start-up phase, through growth stages, all the way to exit.

In the health care and life sciences sectors, she is advisor to clients in a wide range of industries and specialties, including biotechnology, therapeutics, genomics, medtech, healthtech, digital health, artificial intelligence, clinical workflow, and patient management; global leaders in developing, manufacturing, and marketing products for life sciences research and clinical trials; and medical institutions on global expansion matters.

Sage also works extensively with clients in the cleantech, energy transition, infrastructure, and fintech sectors, including investors and companies specializing in conservation and water purification, regulatory technologies involving digital currencies, marine data intelligence, and defense technologies.

Sage was listed in The Top 25 Biotechnology and Life Sciences Attorneys of 2024 by Attorney Intel, which recognizes legal professionals who combine leading sector experience with advanced academic backgrounds in the life sciences fields, enabling them to provide unparalleled guidance across numerous legal issues.

Sage speaks and writes on matters in the health care, life sciences, and technology sectors and is an advocate for women's health and wellness. She is frequently invited to present globally on these topics, including at LSX World Congress, UCSF Rosenman Institute California, Startup Boston, Imperial College London, and The Guildhall.